Sarepta therapeutics announces recipients of the 6th annual route 79, the duchenne scholarship program, for the 2023-2024 academic year

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, today announced 25 recipients of route 79, the duchenne scholarship program for the 2023-2024 academic year. of the 25 recipients, academic scholarships will be awarded to 20 individuals living with duchenne muscular dystrophy and to five siblings of individuals living with duchenne. each recipient will receive a scholarship of up to $5,000. “on behalf of sare.
SRPT Ratings Summary
SRPT Quant Ranking